ClinicalTrials.Veeva

Menu

BACK4 Safety Evaluation

S

SWIMS America Corp.

Status

Completed

Conditions

Safety and Tolerability in Healthy Subjects

Treatments

Device: Treatment with BACK4 System

Study type

Interventional

Funder types

Industry

Identifiers

NCT07153900
SF-B4-001

Details and patient eligibility

About

To characterize the safety of combined RF and EMS therapies with the BACK4 device in healthy volunteers. Subjects will receive 3 treatments of increasing intensity over a one week period.

Enrollment

24 patients

Sex

All

Ages

22 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adults 22-55 years old
  • Able to provide written informed consent

Exclusion criteria

  • Injury within the past 30 days
  • Cancer or cancerous lesions in the treatment area
  • Skin disorders (e.g., eczema, shingles), skin burns, or open wounds
  • Coagulation disorders, phlebitis, or thrombophlebitis
  • Insensitivity to heat
  • Local insensitivity to pain and/or touch
  • Fever, bacterial infection, infectious disease, or tuberculosis
  • Severe hypertension or hypotension
  • Electrical implants (e.g., pacemaker, insulin pump, neurostimulator)
  • History of seizures or recent surgery
  • Known hypersensitivity to device materials
  • Pregnant or breastfeeding women
  • Participation in another clinical trial within 30 days

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

24 participants in 2 patient groups

Hands-on
Active Comparator group
Description:
Treatment delivered by therapist utilizing multipolar electrode
Treatment:
Device: Treatment with BACK4 System
Hands-free
Active Comparator group
Description:
Treatment delivered utilizing fixed pads
Treatment:
Device: Treatment with BACK4 System

Trial contacts and locations

1

Loading...

Central trial contact

Ramona von Leden, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems